Navigation Links
Luminex Corporation To Present At Upcoming Investment Conferences In September
Date:9/12/2012

AUSTIN, Texas, Sept. 12, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that management will present at two upcoming investment conferences, the UBS Global Life Sciences Conference and the Credit Suisse 2012 Small & Mid Cap Conference, both scheduled to take place in New York City.  

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

Patrick J. Balthrop, president and chief executive officer, will present at the UBS Global Life Sciences Conference on September 19, 2012 at 1 p.m. Eastern time, and at the Credit Suisse 2012 Small & Mid Cap Conference on September 21, 2012 at 1:10 p.m. Eastern time.

The presentations will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com.  Simply log on to the web at the address above, go to the Company section and access the Investor Relations link.  Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. We are transforming global healthcare and life-science research through the development, manufacturing, and marketing of proprietary instruments and assays utilizing our xMAP® open-architecture, multi-analyte platform and our MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies that deliver cost-effective and rapid results to clinicians and researchers. Our technology is commercially available worldwide and in use in le
'/>"/>

SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco
2. Luminex Corporation Recognized as Best Technology Company in Austin
3. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
4. Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
5. Luminex Corporation Reports Second Quarter 2012 Results
6. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
7. Luminex Corporation Announces Agreement to Acquire GenturaDx
8. Luminex Corporation Reports First Quarter 2012 Results
9. Genelex Corporation Rolls Out Lifesaving DNA Healthcare System
10. Tranzbyte Corporation Acquires the Exclusive Right to Market Low-Cost, Innovative MRI machines in North and South America
11. American Pacific Corporation Completes Redemption Of $40 Million Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Mar. 05, 2015 Research and Markets ... "Japan Pharma Outlook 2015: Year to Watch out ... report to their offering. The ... from April -2014 (Annexure 1) is a game ... whether generic or innovator. The most of the companies ...
(Date:3/5/2015)... -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a ... targeted antiviral therapies, announced today that it will present ... be held March 8-11, 2015, in Laguna ... , Chief Executive Officer, will provide an overview of ... be available to participate in one-on-one meetings with investors ...
(Date:3/5/2015)... -- According to a new market research ... Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User ... - Analysis & Global Forecast to 2019" , the ... $1,107.4 Million by 2019 from $887.8 Million in 2014, ... 4.5% during the forecast period. Browse ...
Breaking Medicine Technology:Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3ContraVir to Present at 27th Annual ROTH Conference 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4
... 3, 2012 Cardium Therapeutics (NYSE Amex: ... with NYSE Amex LLC (formerly the American Stock Exchange). ... now in excess of the threshold requirements under Section ... (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO ) ...
... Calif., Jan. 3, 2012 BioMarin Pharmaceutical Inc. (Nasdaq: ... New Drug (IND) application for BMN-111, an analog of ... company expects to initiate the Phase 1 trial in ... demonstrated benefits in moderately and severely affected animal models ...
Cached Medicine Technology:Cardium Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines 2Cardium Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines 3Cardium Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines 4BioMarin Announces IND for BMN-111 for Achondroplasia is Active 2BioMarin Announces IND for BMN-111 for Achondroplasia is Active 3BioMarin Announces IND for BMN-111 for Achondroplasia is Active 4
(Date:3/6/2015)... TX (PRWEB) March 06, 2015 ... publishing company, created a unique ‘energy’ experiment to ... lives. , After quick ‘5 -7 ... more than 150+ countries reported their life improving ... respondents reported positive results. , According to research, ...
(Date:3/6/2015)... 2015 Dr. Mark Sowell recently returned from ... AZ. Offering programs for advanced education in the field of ... , As a visiting faculty member of this prestigious ... each time he visits Spear Education to participate in a ... “we are training only the top 10% and those willing ...
(Date:3/6/2015)... Alexandria, Virginia (PRWEB) March 06, 2015 ... today it has awarded five-year accreditation status to seven ... Committee mean that another 1.3 million people can now ... to protect and promote the health of their communities. ... protecting and improving the health of people and communities. ...
(Date:3/5/2015)... March 05, 2015 Shania Twain will ... than a decade. She has hinted that this will be ... seeing her perform one last time. She has had a ... beloved country sweetheart has millions of loyal fans around the world. ... native country, Canada, and on June 30th she will be at ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Risperdal ... in a Pennsylvania mass tort litigation currently underway ... a jury has begun hearing testimony in the ... atypical antipsychotic medication can cause gynecomastia, or male ... in question was filed on behalf of a ...
Breaking Medicine News(10 mins):Health News:250,000+ Person ‘Remote Energy’ Event has 94.2% of Respondents saying “Life Got Better” 2Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 3Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3
... journal Addiction , researchers from Bowling Green State ... and substantially elevated risks for illegal drug use in ... incarcerated in the United States has sharply risen over ... to 2,250,000 in 2006. So too has the number ...
... 28, 2010 (Geneva, Switzerland) At the UN Millennium ... world leaders gathered to review progress on the eight ... ill-health by 2015. As the summit came to a ... $40bn to reach the goals, with particular emphasis on ...
... Steven Reinberg HealthDay Reporter , TUESDAY, Sept. ... C-reactive protein (CRP) can vary among different racial and ... heart-disease risk and the value of cholesterol-lowering drugs, a ... of inflammation, and elevated levels have been linked -- ...
... , TUESDAY, Sept. 28 (HealthDay News) -- Think recess, and ... in the school day set aside for running and playing, ... life. What if your workplace started offering recess on the ... good idea but possibly one of the most solid tactics ...
... treatments for the disease or enable earlier diagnosis, say the ... Dentistry. Pancreatic cancer has the lowest survival rate of all ... stages, late diagnosis and its resistance to chemotherapy and radiation ... Research Fund found that nearly three quarters of pancreatic ...
... your ragweed allergies, according to a study from Queen,s University. ... develop ragweed allergy symptoms more quickly than others. But the ... swing, those symptom differences subside. The team, led ... medicine and microbiology & immunology, exposed 123 participants to ragweed, ...
Cached Medicine News:Health News:Father's incarceration associated with elevated risks of marijuana and other illegal drug use 2Health News:International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving maternal and child health 2Health News:International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving maternal and child health 3Health News:C-Reactive Protein Levels Vary By Race: Study 2Health News:C-Reactive Protein Levels Vary By Race: Study 3Health News:Adding Recess to the Workday Gains Backers 2Health News:Adding Recess to the Workday Gains Backers 3Health News:Adding Recess to the Workday Gains Backers 4Health News:Protein key to growth of pancreatic cancer 2
Angled 45 degree shafts 8 mm from tip to bend with 5 mm tying platform. Serrated handle with dull finish. Overall length 3.3 inches....
Ultra-fine 5 mm tying platform is valuable when manipulating delicate 10-0 and 11-0 sutures. Pin in handle keeps tips in alignment. Shafts available straight or angled 45 degrees, 8 mm from tip. Angl...
Curved shafts and tips with 6 mm tying platform. Wide serrated handle with dull finish. Overall length 4.3 inches....
Ultra-fine tying platform with round knurled handle for fingertip rotational control. Curved shafts. Overall length 3.9 inches....
Medicine Products: